Published in J Pharm Pharm Sci on April 06, 2001
Metformin and exercise in type 2 diabetes: examining treatment modality interactions. Diabetes Care (2011) 0.91
The nephrotoxicity risk in rats subjected to heavy muscle activity. J Sports Sci Med (2009) 0.88
Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy. Adv Drug Deliv Rev (2016) 0.81
Effects of physical activity upon the liver. Eur J Appl Physiol (2014) 0.79
Urinary biomarkers of flame retardant exposure among collegiate U.S. gymnasts. Environ Int (2016) 0.78
Physiological and pharmacokinetic effects of multilevel caging on Sprague Dawley rats under ketamine-xylazine anesthesia. Exp Anim (2016) 0.75
Impact of regular physical activity on weekly warfarin dose requirement. J Thromb Thrombolysis (2016) 0.75
Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin. Rheumatol Int (2014) 0.75
Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism. Cell Biol Toxicol (2006) 1.35
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J Hematother Stem Cell Res (2001) 1.18
Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos (1997) 0.92
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrob Agents Chemother (1989) 0.91
Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review. Curr Med Res Opin (1989) 0.88
Ethnopharmacology of rhinoceros horn. I: Antipyretic effects of rhinoceros horn and other animal horns. J Ethnopharmacol (1990) 0.86
Phylogenetic relationships and evolutionary history of the shrimp genus Penaeus s.l. derived from mitochondrial DNA. Mol Phylogenet Evol (2004) 0.82
Ethnopharmacology of rhinoceros horn. II: Antipyretic effects of prescriptions containing rhinoceros horn or water buffalo horn. J Ethnopharmacol (1991) 0.82
Moclobemide excretion in human breast milk. Br J Clin Pharmacol (1990) 0.82
Dose-dependent pharmacokinetics of metoclopramide in rat: an effect of hemoperfusion? J Pharmacol Exp Ther (1981) 0.82
Propofol and thiopental in a 1:1 volume mixture is chemically stable. Anesth Analg (1998) 0.82
Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers. Eur J Clin Pharmacol (1996) 0.81
Character of adverse effects of prophylactic lidocaine in the coronary care unit. Clin Pharmacol Ther (1986) 0.81
Expression of SCM-1alpha/lymphotactin and SCM-1beta in natural killer cells is upregulated by IL-2 and IL-12. DNA Cell Biol (1999) 0.81
Linearity of metoclopramide kinetics at doses of 5-20 mg. Br J Clin Pharmacol (1988) 0.80
Reassessing models of hepatic extraction. J Biol Phys (2003) 0.79
The pharmacokinetics of captopril in infants with congestive heart failure. Ther Drug Monit (1991) 0.79
Acetylation and pentafluorobenzoylation of lidocaine metabolites in aqueous solution and identification of derivatives by combined gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom (1987) 0.79
An interactive computer program for determining areas bounded by drug concentration curves using lagrange interpolation. J Pharmacol Toxicol Methods (1995) 0.79
Nonlinear pharmacokinetics of mibefradil in the dog. J Pharm Sci (1996) 0.78
Models of hepatic drug elimination. Drug Metab Rev (1992) 0.78
Effect of haemodialysis on metoclopramide kinetics in patients with severe renal failure. Br J Clin Pharmacol (1988) 0.78
Osmotic load from glucose polymers. JPEN J Parenter Enteral Nutr (1991) 0.78
Effects of intravenous infusion of lidocaine on its pharmacokinetics in conscious instrumented dogs. J Pharm Sci (1997) 0.77
Dosimetry estimations for 123I-IAZA in healthy volunteers. J Nucl Med (2001) 0.77
Simplified determination of captopril in plasma by high-performance liquid chromatography. J Chromatogr (1988) 0.77
Effects of taurine supplementation in parenteral nutrition-associated hepatosteatosis and lidocaine metabolism. A study using isolated rat liver perfusion. Drug Metab Dispos (1996) 0.76
Clinical pharmacokinetics of 123I-IAZA in healthy volunteers. Nucl Med Commun (1999) 0.76
Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex. Biol Psychiatry (1993) 0.76
Hydralazine pharmacokinetics and interaction with food: an evaluation of the dog as an animal model. Pharm Res (1990) 0.75
Lithium decreases Gs, Gi-1 and Gi-2 alpha-subunit mRNA levels in rat cortex. Eur J Pharmacol (1991) 0.75
Assay for hydralazine as its stable p-nitrobenzaldehyde hydrazone. Pharm Res (1988) 0.75
Experimental studies of transient mass transfer and reaction in the liver: interpretation with a heterogeneous compartment model. J Pharm Sci (1992) 0.75
Lack of acute effect on lidocaine pharmacokinetics from parenteral nutrition. Ther Drug Monit (1990) 0.75
Accuracy of C-peptide:insulin molar ratio as a measure of hepatic removal of insulin. Diabetes Res Clin Pract (1987) 0.75
Evidence for lidocaine-induced enzyme inactivation. J Pharm Sci (1989) 0.75
Stability problems with hydralazine p-anisaldehyde hydrazone. J Pharm Sci (1989) 0.75
Pharmacokinetics of drugs that inactivate metabolic enzymes. J Pharm Sci (1991) 0.75
Enhancement of bupivacaine toxicity by diltiazem in anaesthetized dogs. Br J Anaesth (1992) 0.75
Sensitive electron-capture gas-liquid chromatographic assay for the de-ethylated metabolite of metoclopramide. J Chromatogr (1979) 0.75
Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination. Drug Metab Dispos (1987) 0.75
Pharmacokinetics of ampicillin during parenteral nutrition. JPEN J Parenter Enteral Nutr (1990) 0.75
Sensitive electron-capture GLC determination of metoclopramide in biological fluids. J Pharm Sci (1978) 0.75
Pharmacokinetic-pharmacodynamic modelling for captopril in healthy anaesthetized piglets. Biopharm Drug Dispos (1996) 0.75
A computer simulation of the food effect: transient changes in hepatic blood flow and Michaelis-Menten parameters as mediators of hepatic first pass metabolism and bioavailability of propranolol. Biopharm Drug Dispos (1990) 0.75
Molecular Differentiation of Fusarium solani f. sp. glycines from Other F. solani Based on Mitochondrial Small Subunit rDNA Sequences. Phytopathology (2000) 0.75
Pharmacokinetics and presystemic gut metabolism of methyldopa in healthy human subjects. J Clin Pharmacol (1995) 0.75
The pharmacokinetics of metoclopramide in rats with experimental renal and hepatic dysfunction. J Pharmacol Exp Ther (1981) 0.75
Hong Kong married abortion applicants: a comparison with married women who elect to complete their pregnancies. J Biosoc Sci (1981) 0.75
Modification of metoclopramide GLC assay: application to human biological specimens. J Pharm Sci (1979) 0.75
Mechanisms of lidocaine kinetics in the isolated perfused rat liver. III. Evaluation of liver models for time-dependent behavior. Drug Metab Dispos (1987) 0.75
Simple and sensitive high-performance liquid chromatographic method for the determination of diltiazem and six of its metabolites in human plasma. J Chromatogr (1992) 0.75
Lack of residual effects of diethyl ether, methoxyflurane, and sodium pentobarbital on lidocaine metabolism in a single-pass isolated rat liver perfusion system. Drug Metab Dispos (1995) 0.75
In vivo metabolism of lidocaine in the rat. Isolation of urinary metabolites as pentafluorobenzoyl derivatives and their identification by combined gas chromatography-mass spectrometry. J Chromatogr (1987) 0.75
Mechanisms of time-dependent kinetics of diltiazem in the isolated perfused rat liver. Drug Metab Dispos (1994) 0.75
Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia. Bone Marrow Transplant (2003) 0.75
Pharmacokinetic approach to the estimation of hepatic removal of insulin. Pancreas (1986) 0.75
Psychological epidemic in Hong Kong. II. Psychological and physiological characteristics of children who were affected. Acta Psychiatr Scand (1982) 0.75
Simple and rapid high-performance liquid chromatographic method for the analysis of sulfinpyrazone and four of its metabolites in human plasma. J Chromatogr (1984) 0.75
Synthesis of gamma-dimethylaminomethyl-alpha-phenylcycloalkyl propionates as potential analgetics. J Med Chem (1970) 0.75
Improved gas-liquid chromatographic-flame ionization detection assay of acetylsalicylic and salicylic acids. J Chromatogr (1979) 0.75
Effects of cholestyramine and parenteral nutrition on hepatic metabolism of lidocaine: a study using isolated rat liver perfusion. JPEN J Parenter Enteral Nutr (1997) 0.75
The influence of orally administered cimetidine and theophylline on the elimination of each drug in patients with chronic airways obstruction. Am Rev Respir Dis (1984) 0.75
Omega-dithiolano amino acids. J Med Chem (1969) 0.75
Renal tubular receptor imaging with iodine-131-labeled peanut lectin: pharmacokinetics and renal clearance mechanism in animals. J Nucl Med (1986) 0.75
Pharmacokinetics of diltiazem in patients undergoing coronary artery bypass grafting. Ther Drug Monit (1992) 0.75
Mechanisms of nonlinear pharmacokinetics of mibefradil in chronically instrumented dogs. J Pharmacol Exp Ther (1996) 0.75
Synthesis of gamma-dimethylamino-alpha-phenylcycloalkyl propionates as potential analgetics. J Med Chem (1970) 0.75
Comparative evaluation of hypnotic efficacy of flunitrazepam in psychiatric in-patients. Acta Psychiatr Scand (1978) 0.75
High-performance liquid chromatographic analysis of mibefradil in dog plasma and urine. J Chromatogr B Biomed Appl (1995) 0.75
Interactions between hydralazine and oral nutrients in humans. Ther Drug Monit (1991) 0.75
The series-compartment model for hepatic elimination. Drug Metab Dispos (1987) 0.75
Effects of light-exposed parenteral nutrition on hepatic function and lidocaine metabolism: a study using isolated rat liver perfusion. Pediatr Res (1996) 0.75
Evaluation of different forms of community meeting in a psychiatric unit in Hong Kong. Br J Psychiatry (1982) 0.75
A pharmacokinetic dosing method for oral theophylline in pediatric patients. Ther Drug Monit (1988) 0.75
Kinetic interactions of lidocaine, diphenhydramine, and verapamil with diltiazem. A study using isolated perfused rat liver. Drug Metab Dispos (1994) 0.75
Mechanisms of lidocaine kinetics in the isolated perfused rat liver. I. Effects of continuous infusion. Drug Metab Dispos (1987) 0.75
Stability of captopril in tap water. Am J Hosp Pharm (1992) 0.75
Psychological epidemic in Hong Kong. I. Epidemiological study. Acta Psychiatr Scand (1982) 0.75
Effect of protein and calorie malnutrition on drug metabolism in rat - in vitro. J Pharm Pharm Sci (2006) 0.75
Effects of parenteral nutrition on hepatic elimination of lidocaine: a study using the isolated perfused rat liver. J Pharmacol Exp Ther (1990) 0.75
Effects of methoxyflurane anesthesia on the pharmacokinetics of 125I-IAZA in Sprague-Dawley rats. Nucl Med Biol (1999) 0.75